combination therapy with glp-1 receptor agonist and sglt2 inhibitor Diabetic Agents, From Metformin to Inhibitors GLP1 Agonists: JACC Focus Seminar Combining glucagon-like peptide-1 receptor agonists
Description
Sanders didnt hold back: Treat the American people the same way that you treat people all over the world

New research suggests the amount of weight patients lose after starting these medications could strongly influence their future risk of serious obesity-related diseases

10.1016/S0140-6736(17)30069-7 45 LeiterL

They were additionally compared across the GLP-1RA and control groups to check for any differences

Engel M., Hoffmann T., Manhart S., et al., Rigidity and Flexibility of Dipeptidyl Peptidase IV: Crystal Structures of and Docking Experiments With DPIV, Journal of Molecular Biology 355, no

I'm curious if we're seeing it for people who are staying on the medication
